Sfoglia per AUTORE
LI Q
Collezione AOU Città della Salute di Torino
Items : 3
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2025 Jan;12(1):e45-e56. doi: 10.1016/S2352-3026(24)00320-X.
2025
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Mina R; Mylin AK; Yokoyama H; Magen H; Alsdorf W; Minnema MC; Shune L; Isufi I; Harrison SJ; Shah UA; Schecter JM; Vogel M; Lendvai N; Gries KS; Katz EG; Slaughter A; Lonardi C; Gilbert J; Li Q; Deraedt W; Filho OC; Patel N; Florendo E; Karlin L; Weisel K;
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2023 Nov 30;12(11):2229-2244. doi: 10.21037/tlcr-23-577. Epub 2023 Oct 26.
2023
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Chen X; Zhang S; Gu Y; Tang Y; Mu X; Qin J; Yang X; He M; Liu Y; Zhong W; Gao J; Chen M; Zhao J; Gao X; Liu J; Zhang H; Shi Y; Zhao D; Shen F; Liu X; Zhang D; Pang L; Meng Q; Guo Y; Zhang Y; Li W; Xing P; Cheng Y; Xin T; et alii...
Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study. in Hypertension (Dallas, Tex. : 1979) / Hypertension. 2019 Dec;74(6):1532-1540. doi: 10.1161/HYPERTENSIONAHA.119.13833. Epub 2019 Nov 4.
2019
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Buffolo F; Li Q; Monticone S; Heinrich DA; Mattei A; Pieroni J; Mei M; Yang S; Hu YH; Yang MC; Sabbadin C; Pizzolo F; Giacchetti G; Fallo F; Veglio F; Reincke M; Wu VC; Mulatero P;